PRKACA and neoplasm: In contrast, when transplanting B16F10-Cas9 cells expressing two NTC sgRNAs or two sgRNAs targeting Prkaca and Prkacb into the NCG mice, we did not observe significant difference in tumor growth or host survival time (Fig. 6E and Supplementary Fig. S9C).